We are pioneering a unique set of therapeutic and drug profiling capabilities based on our revolutionary ability to 3D bioprint tissues that mimic key aspects of human biology and disease. We intend to fundamentally alter the drug discovery landscape by the development of novel therapies for disease which have a much higher chance of efficacy in the clinic focused on human primary cell 3D models of disease that more faithfully recapitulate disease processes. Learn more at www.organovo.com.
Industry
Biotechnology Research, Securities and Commodity Contracts Intermediation and Brokerage, Finance and Insurance
HQ Location
11555 Sorrento Valley Rd
Suite 100
San Diego, California 92121, US
Keywords
3D bioprinting3D printingDrug discovery and developmentHuman disease researchHuman disease modelskit stockpurchase serviceextension labeltaxonomy extensionmimic key